Glucosylceramide Synthase Inhibitor [EPC]

2827 reported adverse events

Drugs of this class: MIGLUSTAT ELIGLUSTAT

These side effects are most commonly reported by patients taking drugs of the Glucosylceramide Synthase Inhibitor [EPC] class:

# Side effect Count
0 WEIGHT DECREASED 250
1 DIARRHOEA 205
2 WEIGHT INCREASED 187
3 DEATH 164
4 PRODUCT DOSE OMISSION IN ERROR 162
5 SEIZURE 122
6 OFF LABEL USE 120
7 FATIGUE 115
8 CONDITION AGGRAVATED 114
9 PNEUMONIA 105
See all common reactions for Glucosylceramide Synthase Inhibitor [EPC]

Drugs of the Glucosylceramide Synthase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NIEMANN-PICK DISEASE 97 0.8151
1 TAY-SACHS DISEASE 5 0.4167
2 CHITOTRIOSIDASE INCREASED 15 0.2459
3 GAUCHER'S DISEASE 6 0.1091
4 LIPIDOSIS 6 0.0984
5 BASOPHILIA 3 0.0400
6 NERVE CONDUCTION STUDIES ABNORMAL 4 0.0240
7 GASTROSTOMY 32 0.0206
8 GASTROSTOMY TUBE SITE COMPLICATION 4 0.0200
9 ANGIOTENSIN CONVERTING ENZYME INCREASED 3 0.0183
See all enriched reactions for Glucosylceramide Synthase Inhibitor [EPC]